[CHRS] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[CHRS] Coherus BioSciences, Inc.
Announcement Date
08-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- -64.96%
YoY- -141.00%
Quarter Report
CHRS's Result
CHRS's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 58,716 32,436 45,352 45,424 60,151 60,115 73,371 -13.83%
PBT -42,869 -75,729 -58,870 -86,650 -50,150 -96,084 -45,725 -4.21%
Tax 11,560 -949 7,377 6,201 6,137 15,159 5,793 58.70%
NP -42,869 -74,780 -66,247 -92,851 -56,287 -111,243 -45,725 -4.21%
Tax Rate - - - - - - - -
Total Cost 101,585 107,216 111,599 138,275 116,438 171,358 119,096 -10.08%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -73.01 -230.55 -146.07 -204.41 -93.58 -185.05 -62.32 11.16%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -0.60 -12.66%
EPS Diluted -0.49 -0.94 -0.85 -1.19 -0.73 -1.44 -0.60 -12.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.